After transiently or stably suppressing NAP1L1 expression in breast cancer cells by respectively using siRNA or lentivirus-mediated shRNA, it was observed that the ability of cell proliferation and EDU staining was significantly reduced in vitro. The gene discussed is NAP1L1; the disease is breast carcinoma.